EQS-News: Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns
EQS-News: Epigenomics AG / Key word(s): Personnel Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns 12.04.2023 / 2...
Stay updated with breaking news from Epi Procolon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Epigenomics AG / Key word(s): Personnel Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns 12.04.2023 / 2...
EQS-News: Epigenomics AG / Key word: Personnel Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns 12.04.2023 / 20:05 CET/CEST The issuer is solely responsible for the... | April 12, 2023
Blood-based biomarker tests for colorectal cancer could soon be cleared by U.S. regulators, opening the doors to a new, more convenient way to screen for the disease.
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Chief Executive Officer Greg Hamilton Resigns 12.04.2023 / 20:05 CET/CESTThe issuer is solely responsible for the content of this announcement.Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns Berlin (Germany), April 12, 2023 - The Chief Ex...
If colon cancer blood tests eventually win FDA approval and Medicare reimbursement, their use could become more widespread. But first this approach needs to match up against the current standard.